New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 21, 2014
06:19 EDTVSIVitamin Shoppe recommended ahead of Q2 report at Goldman
Goldman believes Vitamin Shoppe (VSI) competitive pressures are overblown and that the company has relatively low overlap with GNC (GNC) and that recent price cuts have had minimal impact. The firm expects Vitamin Shoppe's Q2 to mark the beginning of sharp earnings acceleration and better execution and recommends buying shares ahead of the Q2 report. Shares are rated Conviction Buy with a $60 price target.
News For VSI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 20, 2014
14:46 EDTVSIVitamin Shoppe may hire adviser amid pressure for deal, Reuters says
Vitamin Shoppe (VSI), which has been urged by activist shareholders to consider a sale, is speaking to banks and may hire a financial adviser, according to Reuters, citing people familiar with the matter. Note that Reuters previously reported on September 18 that some large Vitamin Shoppe holders have urged the company to consider a sale to rival GNC Holdings (GNC) or to a private equity buyer. That same day, The Financial Times reported that GNC was considering a possible sale after receiving attention from private equity suitors. Following this latest report from Reuters, shares of Vitamin Shoppe are up 6.7% to $45.23 in afternoon trading, while GNC shares are up over 3% to $38.88. Reference Link
14:33 EDTVSIVitamin Shoppe up over 6%, near highs of session
14:21 EDTVSIVitamin Shoppe may appoint adviser as activist pressure continues, Reuters says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use